Anpario plc (LON:ANP – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 398.50 ($5.01) and last traded at GBX 389 ($4.89), with a volume of 46046 shares changing hands. The stock had previously closed at GBX 385 ($4.84).
Wall Street Analysts Forecast Growth
A number of analysts recently commented on ANP shares. Canaccord Genuity Group upped their price target on shares of Anpario from GBX 340 ($4.28) to GBX 370 ($4.65) and gave the company a “buy” rating in a research note on Wednesday, September 18th. Shore Capital reaffirmed a “house stock” rating on shares of Anpario in a report on Wednesday, September 11th.
Get Our Latest Stock Report on Anpario
Anpario Trading Up 1.0 %
Insider Buying and Selling
In related news, insider Karen Prior sold 14,000 shares of Anpario stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of GBX 380 ($4.78), for a total transaction of £53,200 ($66,926.66). 30.51% of the stock is currently owned by corporate insiders.
About Anpario
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Read More
- Five stocks we like better than Anpario
- Upcoming IPO Stock Lockup Period, Explained
- 3 Must-Hold Stocks with Double-Digit Upside for 2025
- 3 Stocks to Consider Buying in October
- Micron: Why Now Is the Time to Be Brave
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 3 Stocks That Wall Street Insiders Can’t Stop Buying
Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.